Contribution of Technology and Exchange Agreement [Amendment No. 1] - Donald L Morton and CancerVax Corp.
FIRST AMENDMENT TO
CONTRIBUTION OF TECHNOLOGY AND EXCHANGE AGREEMENT
This First Amendment to the Contribution and Technology Exchange
Agreement ("FIRST AMENDMENT") is made and entered into as of this 1st day of
May, 2002 ("EFFECTIVE DATE"), between Donald L. Morton, M.D. ("MORTON"), and
CancerVax Corporation, a Delaware corporation, ("CANCERVAX"). This First
Amendment amends the Contribution and Technology Exchange Agreement between the
parties dated as of December 15, 2000 (the "AGREEMENT").
RECITALS
A. Morton and CancerVax are parties to the Agreement, dated
December 15, 2000, relating to a contribution of certain technology to
CancerVax.
B. The parties desire to amend the Agreement to add U.S. Patent
Application SN 07/431,533 to the list of patents and patent applications
included in Appendix A that were contributed by Morton to CancerVax, upon the
terms and conditions set forth herein.
NOW THEREFORE, the parties hereby agree as follows:
1. Appendix A of the Agreement, entitled "PATENT RIGHTS," is
amended by adding U.S. Patent Application SN 07/431,533 as one of the patents or
patent applications that have been contributed by Morton to CancerVax. Amended
Appendix A is attached to and incorporated in this First Amendment.
2. All other terms and conditions of the Agreement shall remain
in full force and effect.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
<PAGE>
IN WITNESS WHEREOF, the undersigned have executed this Amendment
effective as of the date and year first above written.
Donald L. Morton, M.D.
/s/ Donald L. Morton
------------------------------------
Address: 1374 Bella Oceana Vista
Pacific Palisades, CA 90630
CancerVax Corporation
By: /s/ David F. Hale
--------------------------------
David F. Hale
Its: President and CEO
Address: 5931 Darwin Court
Carlsbad, CA 92008
[SIGNATURE PAGE TO FIRST AMENDMENT TO
CONTRIBUTION OF TECHNOLOGY AND EXCHANGE AGREEMENT]
2
<PAGE>
EXHIBIT A
PATENT RIGHTS
1. ASSIGNED PATENT RIGHTS
TUMOR ASSOCIATED ANTIGEN FETAL ANTIGEN
USSN 07/431,533 USSN 09/519,920
U.S. Patent 5,882,654
U.S. Patent 5,840,317
U.S. Patent 5,993,828
USSN 09/369,668
European Patent 0498851
Austrian Patent E132629
Belgian Patent 0498851
Swiss Patent 0498851
German Patent 69024659.5
Denmark Patent 0498851
Spanish Patent 2084715
French Patent 2084715
U.K. Patent 2084715
Italian Patent 2084715
Luxembourg Patent 2084715
Netherland Patent 2084715
Swedish Patent 2084715
Australian Patent 661816
Japanese Published Patent Application No. 90/500470
Canadian Patent Application 2,072,620
3